½ÃÀ庸°í¼­
»óǰÄÚµå
1567215

¾ÆÆ÷Åä½Ã½º ½ÃÀå : ¿ëµµº°, ¸ð´Þ¸®Æ¼º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Apoptosis Market, By Application, By Modality, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾ÆÆ÷Åä½Ã½º ¼¼°è ½ÃÀåÀº 2024³â 38¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 56¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 5.8%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 38¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£ 2024-2031³â CAGR: 5.80% 2031³â °¡Ä¡ ¿¹Ãø 56¾ï 5,000¸¸ ´Þ·¯
±×¸². ¾ÆÆ÷Åä½Ã½º ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Apoptosis Market-IMG1

ÀϹÝÀûÀ¸·Î ÇÁ·Î±×·¥µÈ ¼¼Æ÷ »ç¸ê·Î ¾Ë·ÁÁø ¾ÆÆ÷Åä½Ã½º´Â ¿øÄ¡ ¾Ê´Â ¼¼Æ÷³ª ¼Õ»óµÈ ¼¼Æ÷¸¦ ÅëÁ¦µÈ ¹æ½ÄÀ¸·Î Á¦°ÅÇÏ´Â »ý¹°Ã¼ÀÇ ÀÚ¿¬Àû °úÁ¤ÀÔ´Ï´Ù. ¾ÆÆ÷Åä½Ã½ºÀÇ Á¶Àý Àå¾Ö´Â ¾Ï, ÀÚ°¡¸é¿ªÁúȯ, ½Å°æÅðÇ༺ Áúȯ°ú °°Àº º´Àû »óŸ¦ ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ÁúȯÀÇ Ä¡·á¸¦ À§ÇØ ¾ÆÆ÷Åä½Ã½ºÀ» Á¶ÀýÇÏ´Â »õ·Î¿î Ç¥Àû Ä¡·áÁ¦ÀÇ ¿¬±¸ °³¹ßÀÌ ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾ÆÆ÷Åä½Ã½ºÀÇ ºÐÀÚÀû ±âÀüÀÌ ¹àÇôÁö°í »õ·Î¿î °æ·Î ¾ïÁ¦Á¦°¡ °³¹ßµÊ¿¡ µû¶ó ±× ¿ëµµ°¡ È®´ëµÇ¸é¼­ Àü ¼¼°èÀûÀ¸·Î ¾ÆÆ÷Åä½Ã½º Á¶Àý ¾à¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¾Ï ¹× ±âŸ ¾ÆÆ÷Åä½Ã½º °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¦¾àȸ»çÀÇ R&D ÅõÀÚ Áõ°¡, ½Å±Ô Ç¥Àû ¾ÆÆ÷Åä½Ã½º Á¶Àý ¾à¹°¿¡ ´ëÇÑ USFDA ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ¿¬°£ 70% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¾à¹° °³¹ß ¹× ÀÓ»ó½ÃÇè¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±àÁ¤ÀûÀÎ Ãø¸éÀ¸·Î, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä« µî ½ÅÈï ½ÃÀåÀº ÀÌ Áö¿ªÀÇ ÀÇ·áºñ Áõ°¡¿Í ¾çÁúÀÇ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ ½ÃÀå Ç÷¹À̾°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º´¿ë¿ä¹ý ¹× ÆÄÀÌÇÁ¶óÀÎ ÀǾàǰ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È »õ·Î¿î Àü¸ÁÀÌ °è¼Ó âÃâµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¦°øÇÏ´Â ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼® º¸°í¼­ÀÔ´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott, Roche, Novartis, Bristol-Myers Squibb, Merck, Pfizer µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¾ÆÆ÷Åä½Ã½º ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¾ÆÆ÷Åä½Ã½º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • Porters ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¾ÆÆ÷Åä½Ã½º ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾ÆÆ÷Åä½Ã½º ½ÃÀå, ¿ëµµº°, 2019-2031³â

  • Á¾¾çÇÐ
  • ½Å°æº¯¼ºÁúȯ
  • ÀÚ°¡¸é¿ªÁúȯ
  • ½ÉÇ÷°üÁúȯ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¾ÆÆ÷Åä½Ã½º ½ÃÀå, ¸ð´Þ¸®Æ¼º°, 2019-2031³â

  • ¾ÆÆ÷Åä½Ã½º ¾î¼¼ÀÌ
  • ¾ÆÆ÷Åä½Ã½º Ç×ü
  • ¾ÆÆ÷Åä½Ã½º ¾ïÁ¦Á¦¿Í À¯µµÁ¦

Á¦7Àå ¼¼°èÀÇ ¾ÆÆ÷Åä½Ã½º ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â

  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸±â°ü
  • °è¾à ¿¬±¸±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¾ÆÆ÷Åä½Ã½º ½ÃÀå, Áö¿ªº°, 2019-2031³â

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories
    • GE Healthcare
    • Becton, Dickinson and Company(BD)
    • Promega Corporation
    • Sartorius AG
    • Abcam plc.
    • Biotium
    • Geno Technology
    • BioTek Instruments
    • Canvax
    • Abnova
    • Creative Bioarray
    • PerkinElmer
    • Danaher Corporation
    • Bio-Techne
    • GeneCopoeia, Inc.
    • Takara Bio Inc.
    • Bioss Antibodies

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

Á¦11Àå Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 24.10.22

The Global Apoptosis Market is estimated to be valued at USD 3.81 Billion in 2024 and is expected to reach USD 5.65 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 3.81 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.80% 2031 Value Projection: US$ 5.65 Bn
Figure. Apoptosis Market Share (%), By Region, 2024
Apoptosis Market - IMG1

Apoptosis, commonly known as programmed cell death, is a natural process in living organisms to remove unnecessary or damaged cells in a controlled manner. Dysregulation of apoptosis can lead to pathogenic conditions like cancer, autoimmune disorders, and neurodegenerative diseases. Therefore, research and development of new targeted therapeutics to modulate apoptosis for treatment of such diseases is contributing to the growth of this market. Advancements in understanding the molecular mechanisms of apoptosis and development of novel pathway inhibitors are expanding the applications and driving the demand for apoptosis modulating drugs globally.

Market Dynamics:

Rise in prevalence of cancer and other apoptosis related disorders, increasing R&D investments by pharmaceutical companies, and growing USFDA approvals for novel targeted apoptosis modulating drugs are some of the major factors projected to propel the global apoptosis market during the forecast period. According to WHO, cancer burden is expected to grow by 70% in the next two decades. However, high costs associated with drug development and clinical trials may hamper market growth. On the positive side, emerging markets such as Asia Pacific and Latin America offer lucrative opportunities for market players due to growing healthcare expenditure and demand for quality care in these regions. Furthermore, ongoing research on combination therapies and pipeline drugs will continue creating new prospects over the coming years.

Key features of the study:

This report provides in-depth analysis of the global apoptosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global apoptosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbot, Roche, Novartis, Bristol-Myers Squibb, Merck, and Pfizer

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global apoptosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global apoptosis market.

Detailed Segmentation-

  • By Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Oncology
    • Neurodegenerative Diseases
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Others
  • By Modality Insights (Revenue, USD Bn, 2019 - 2031)
    • Apoptosis Assays
    • Apoptosis Antibodies
    • Apoptosis Inhibitors and Inducers
  • By End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Contract Research Organizations
    • Ohers
  • Regional Insights (Revenue, USD Bn 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories
    • GE Healthcare
    • Becton, Dickinson and Company (BD)
    • Promega Corporation
    • Sartorius AG
    • Abcam plc.
    • Biotium
    • Geno Technology
    • BioTek Instruments
    • Canvax
    • Abnova
    • Creative Bioarray
    • PerkinElmer
    • Danaher Corporation
    • Bio-Techne
    • GeneCopoeia, Inc.
    • Takara Bio Inc.
    • Bioss Antibodies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Modality
    • Market Snapshot, By End User
    • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Apoptosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Apoptosis Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oncology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Neurodegenerative Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Autoimmune Disorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cardiovascular Diseases
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Apoptosis Market, By Modality, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Apoptosis Assays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Apoptosis Antibodies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Apoptosis Inhibitors and Inducers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Apoptosis Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic and Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Apoptosis Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Merck KGaA
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GE Healthcare
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Becton, Dickinson and Company (BD)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Promega Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sartorius AG
    • Abcam plc.
    • Biotium
    • Geno Technology
    • BioTek Instruments
    • Canvax
    • Abnova
    • Creative Bioarray
    • PerkinElmer
    • Danaher Corporation
    • Bio-Techne
    • GeneCopoeia, Inc.
    • Takara Bio Inc.
    • Bioss Antibodies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦